1-2 of 2
Eric Gustafson, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Pembrolizumab in Relapsed/Refractory Classical Hodgkin Lymphoma: Primary End Point Analysis of the Phase 2 Keynote-087 Study

Craig H. Moskowitz, MD, Pier Luigi Zinzani, MD PhD, Michelle A. Fanale, MD, Philippe Armand, MD PhD, Nathalie A. Johnson, John A. Radford, MD, Vincent Ribrag, MD, Daniel Molin, MD PhD, Theodoros P. Vassilakopoulos, MD PhD, Akihiro Tomita, MD PhD, Bastian von Tresckow, MD, Margaret A. Shipp, MD, Eric Gustafson, PhD, Yinghua Zhang, PhD, Alejandro Daniel Ricart, MD, Arun Balakumaran, MD PhD SM, Robert W Chen, MD
Journal: Blood
Blood (2016) 128 (22): 1107.
https://doi.org/10.1182/blood.V128.22.1107.1107
Published: 2016
Journal Articles

Phase 1b Study of Pembrolizumab in Patients with Relapsed/Refractory Primary Mediastinal Large B-Cell Lymphoma: Results from the Ongoing Keynote-013 Trial

Pier Luigi Zinzani, MD PhD, Vincent Ribrag, MD, Craig H. Moskowitz, MD, Jean-Marie Michot, MD, John Kuruvilla, MD, Arun Balakumaran, MD PhD SM, Yayan Zhang, PhD, Patricia Marinello, PharmD, Sabine Chlosta, MD, Eric Gustafson, PhD, Margaret A. Shipp, MD, Philippe Armand, MD PhD
Journal: Blood
Blood (2016) 128 (22): 619.
https://doi.org/10.1182/blood.V128.22.619.619
Published: 2016